Lybrido for Female Sexual Dysfunction
Public ClinicalTrials.gov record NCT01432665. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Lybrido study is a double-blind, randomized, placebo-controlled study with a 4-week baseline establishment period, 16 week treatment period and a follow up period for a total of 26 weeks on study. Subjects are randomly to one of seven treatment arms. The study investigates the effective dose of Lybrido in increasing the number of satisfactory sexual episodes in the domestic setting in 210 healthy female subjects with hypoactive sexual desire disorder and low sensitivity for sexual cues (30 subjects per group).
Study identification
- NCT ID
- NCT01432665
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 196 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 70 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2011 (Type not available)
- Primary completion
- May 2013 (Actual)
- Completion
- Not listed
- Last update posted
- Jul 29, 2013
Started 2011
United States locations
- U.S. sites
- 14
- U.S. states
- 7
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| San Diego Sexual Medicine | San Diego | California | 92120 | — |
| The Center for Vulvovaginal Disorders | Washington D.C. | District of Columbia | 20037 | — |
| Meridien Research | Brooksville | Florida | 34601 | — |
| Segal Institute Women's Health Clinic | North Miami | Florida | 33161 | — |
| Compass Research | Orlando | Florida | 32806 | — |
| Miami Research Associates | South Miami | Florida | 33143 | — |
| Meridien Research | St. Petersburg | Florida | 34203 | — |
| Comprehensive Clinical Trials, LLC | West Palm Beach | Florida | 33409 | — |
| Annapolis Sexual Wellness Center | Annapolis | Maryland | 21401 | — |
| Maryland Prime Care Physicians | Stevensville | Maryland | 21666 | — |
| Center for Sexual Medicine at Sheppard Pratt | Townson | Maryland | 22104 | — |
| Women's Health Research Center | Plainsboro | New Jersey | 08536 | — |
| Michael A. Werner, MD PC | Purchase | New York | 10577 | — |
| Philadelphia Clinical Research | Philadelphia | Pennsylvania | 19114 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01432665, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 29, 2013 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01432665 live on ClinicalTrials.gov.